Crossmark

Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy

Crossref DOI link: https://doi.org/10.1245/s10434-021-10407-1

Published Online: 2021-07-13

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tonneson, Jennifer E.

Hoskin, Tanya L.

Durgan, Diane M.

Corbin, Kimberly S.

Goetz, Matthew P.

Boughey, Judy C.
License Information

Text and Data Mining valid from 2021-07-13

Version of Record valid from 2021-07-13
More Information

Article History

Received: 7 April 2021

Accepted: 21 June 2021

First Online: 13 July 2021

Disclosures

: Dr. Judy Boughey receive research support from Lilly for clinical trial. Dr. Matthew Goetz receives consulting fees to institution from Eagle Pharmaceuticals, Lilly, Biovica, Novartis, Sermonix, Context Pharm, Pfizer, Biotheranostics, and AstraZeneca and Grant funding to institution from Pfizer, Sermonix, and Lilly.

Document is current

Any future updates will be listed below